5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 18.54▲ | 18.61▼ | 18.61▼ | 18.78▼ | 18.66▼ |
MA10 | 18.56▲ | 18.72▼ | 18.76▼ | 18.69▼ | 18.90▼ |
MA20 | 18.73▼ | 18.90▼ | 18.97▼ | 18.70▼ | 19.07▼ |
MA50 | 19.00▼ | 19.02▼ | 18.93▼ | 19.51▼ | 16.85▲ |
MA100 | 18.99▼ | 18.88▼ | 18.87▼ | 19.07▼ | 13.44▲ |
MA200 | 18.87▼ | 18.47▲ | 18.52▲ | 17.51▲ | 12.28▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.044▼ | -0.062▼ | 0.066▲ | -0.302▼ |
RSI | 42.860▼ | 40.231▼ | 41.226▼ | 48.134▼ | 51.931▲ |
STOCH | 32.950 | 13.975▼ | 9.157▼ | 47.867 | 27.195 |
WILL %R | -39.683 | -77.108▼ | -77.108▼ | -66.447 | -71.233 |
CCI | 0.391 | -78.704 | -86.991 | -76.592 | -37.457 |
Thursday, May 22, 2025 01:44 PM
Agreement would extend Nexxen's global ACR data exclusivity with VIDAA, while adding display ad monetization exclusivity across VIDAA's media in Nort ...
|
Thursday, May 22, 2025 03:50 AM
Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be conducted by Dr. Hyon Choi at Massachusetts General Hospital and will compare ...
|
Tuesday, May 20, 2025 05:30 AM
As ACR accelerates its aggressive growth strategy—completing 10 acquisitions since 2016, the company has leaned on strategic technology partners to ensure its operations remain secure ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/05/25 | 18.45 | 18.61 | 18.45 | 18.61 | 8,217 |
21/05/25 | 19.00 | 19.20 | 18.34 | 18.49 | 36,700 |
20/05/25 | 19.05 | 19.25 | 18.76 | 18.80 | 30,597 |
19/05/25 | 19.00 | 19.62 | 19.00 | 19.10 | 32,619 |
16/05/25 | 18.80 | 19.32 | 18.80 | 18.90 | 25,540 |
15/05/25 | 18.57 | 19.15 | 18.57 | 18.77 | 27,618 |
14/05/25 | 18.44 | 18.86 | 18.44 | 18.64 | 21,952 |
13/05/25 | 18.79 | 19.13 | 18.55 | 18.59 | 32,153 |
12/05/25 | 18.51 | 19.0329 | 18.2298 | 18.58 | 21,765 |
09/05/25 | 18.40 | 18.83 | 18.10 | 18.42 | 33,512 |
|
|
||||
|
|
||||
|
|